Literature DB >> 10955751

Influence of peak expiratory flow monitoring on an asthma self-management education programme.

A López-Viña1, E del Castillo-Arévalo.   

Abstract

We assessed whether peak expiratory flow monitoring added to a self-management education programme reduced morbidity and improved pulmonary function and adherence to treatment in 100 asthma patients (aged 17-65 years) with adequate treatment and regular 1-year follow-up. Patients randomized to the experimental group used peak expiratory flow readings as the basis for their therapeutic plan coupled with educational intervention, whereas patients in the control group received the same educational intervention and used symptoms only to guide self-management. Morbidity parameters, functional status and adherence to medical regimens improved in both groups, although the percentage of patients with satisfactory adherence was significantly better in the group with peak expiratory flow monitoring (83%) than in controls (52%) (P = 0.05). The multivariate analysis showed that severity of asthma (odds ratio 9.28, 95% confidence interval 1.87-45.96, P = 0.006 for moderate asthma) and type of self-management education programme (odds ratio: 6.19; 95% confidence interval: 2.04-18.81; P = 0.001 for the use of peak expiratory flow readings) were the only independent predictors of adherence to treatment. However, a statistically significant association between adherence and use of peak expiratory flow monitoring was only found in patients with moderate asthma (P = 0.0009). We conclude that peak expiratory flow monitorization in optimal conditions (adequate medical regimen, individualized self-management education and regular follow-up) showed a beneficial effect on adherence to prescribed regimens only in patients with moderate asthma.

Entities:  

Mesh:

Year:  2000        PMID: 10955751     DOI: 10.1053/rmed.2000.0815

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Objective airway monitoring improves asthma control in the cold and flu season: a cluster randomized trial.

Authors:  Susan L Janson; Kelly Wong McGrath; Jack K Covington; Robert B Baron; Stephen C Lazarus
Journal:  Chest       Date:  2010-06-10       Impact factor: 9.410

Review 2.  Interventions for enhancing medication adherence.

Authors:  Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes
Journal:  Cochrane Database Syst Rev       Date:  2014-11-20

3.  Individualized asthma self-management improves medication adherence and markers of asthma control.

Authors:  Susan L Janson; Kelly Wong McGrath; Jack K Covington; Su-Chun Cheng; Homer A Boushey
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

Review 4.  Patient-Centered Outcomes of Medication Adherence Interventions: Systematic Review and Meta-Analysis.

Authors:  Vicki S Conn; Todd M Ruppar; Maithe Enriquez; Pamela S Cooper
Journal:  Value Health       Date:  2016-01-14       Impact factor: 5.725

Review 5.  Patient Self-Management of Asthma Using Mobile Health Applications: A Systematic Review of the Functionalities and Effects.

Authors:  Mehrdad Farzandipour; Ehsan Nabovati; Reihane Sharif; Marzieh Heidarzadeh Arani; Shima Anvari
Journal:  Appl Clin Inform       Date:  2017-12-14       Impact factor: 2.342

6.  Predictive Regression Equations of Flowmetric and Spirometric Peak Expiratory Flow in Healthy Moroccan Children.

Authors:  Khalid Bouti; Jouda Benamor; Jamal Eddine Bourkadi
Journal:  J Clin Diagn Res       Date:  2017-08-01

7.  Maximal inspiratory and expiratory flow at moderate altitude: a study of a Latin American population.

Authors:  Laura Gochicoa-Rangel; Keylin Yaoska Rodríguez-Peralta; Ana Karen Gutiérrez-Bautista; Carlos Guzmán-Valderrábano; Rosario Fernández-Plata; Luis Torre-Bouscoulet; David Martínez-Briseño
Journal:  BMC Pulm Med       Date:  2022-04-19       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.